Deep Brain Stimulation (DBS)

Deep brain stimulation is a surgical treatment in which thin electrodes are placed in a precisely targeted area of the brain and connected to a small pulse generator implanted under the skin of the chest. The generator sends continuous, finely tuned electrical impulses that help regulate the irregular brain signaling responsible for tremor, stiffness and involuntary movement.

DBS is often described as a “brain pacemaker,” and the comparison is a reasonable one: no brain tissue is removed or destroyed, stimulation can be adjusted from outside the body at any time, and the system can be switched off or removed if it no longer serves the patient. This reversibility is the key difference between DBS and lesioning procedures such as MRgFUS.

DBS has been in clinical use since the late 1990s and is an established, guideline-supported treatment for Parkinson’s disease, essential tremor and dystonia. It is not an experimental procedure.

In movement disorders, specific brain circuits fire in an abnormal, over-synchronized rhythm. Medication tries to correct this chemically, which is why its effect rises and falls with each dose. DBS instead works electrically and continuously, smoothing out the peaks and troughs that medication alone often leaves behind.

The electrode target is chosen according to the underlying condition and the symptoms troubling the patient most:

The same underlying technology (an implanted, adjustable electrode delivering continuous stimulation to a specific brain target) is also used, for a small number of carefully selected patients, in severe, treatment-resistant psychiatric conditions: obsessive-compulsive disorder (OCD), major depressive disorder, and Tourette syndrome. The targets used differ from those used in movement disorders, and the path to surgery is different in an important way: candidacy is decided jointly by a psychiatric and neurosurgical team working together, not by the neurosurgical team alone, and it is considered only after thorough, appropriately delivered standard psychiatric treatment has not provided adequate relief.

Programming for psychiatric indications tends to be a longer, more gradual process than for movement disorders, carried out in close coordination with the patient’s psychiatric team, and ongoing psychiatric care continues throughout. DBS is added to psychiatric treatment in these cases, not a replacement for it. Full detail on candidacy, evaluation and realistic treatment goals for each condition is provided on the relevant condition page: Obsessive-Compulsive Disorder, Major Depressive Disorder, and Tourette Syndrome.

DBS is also used for a small number of patients with drug-resistant epilepsy, most often targeting the thalamus, to reduce seizure frequency when seizures do not arise from a single, safely removable focus. As with the psychiatric indications above, candidacy is decided by a multidisciplinary epilepsy team, not by the neurosurgical team alone, and DBS is one of more than one neuromodulation option discussed for this group of patients — see our Epilepsy page for the full picture, including how DBS and vagus nerve stimulation relate to one another and to resective surgery. As with other indications, DBS for epilepsy reduces seizure frequency and severity in many appropriately selected patients; it does not reliably eliminate seizures, and realistic goals are set individually.

Candidacy is decided on an individual basis, but most patients who benefit share a recognizable pattern. For Parkinson’s disease, the response to levodopa matters more than any other single factor: as a general rule, symptoms that improve when medication is working are the symptoms most likely to improve with DBS. Tremor is a notable exception, as it can respond to stimulation even when it responds poorly to medication.

DBS is generally not recommended where there is significant cognitive decline, uncontrolled psychiatric illness, an unstable general medical condition, or a diagnosis of atypical parkinsonism (such as multiple system atrophy or progressive supranuclear palsy) rather than Parkinson’s disease itself. Part of the value of thorough evaluation is identifying these factors before any surgical plan is made.

Two elements of assessment carry particular weight:

• Levodopa response testing. Motor symptoms are assessed both “on” and “off” medication. A strong, if incomplete, response to levodopa is one of the best available predictors of a good response to DBS in Parkinson’s disease.
• Cognitive and psychiatric assessment. A structured neuropsychological and mood assessment is a standard, necessary part of evaluation before DBS. Significant uncontrolled depression or cognitive decline generally weighs against surgery, since stimulation and the surgical process itself can be harder to tolerate and less beneficial in these circumstances.

A surgical evaluation for DBS is typically appropriate when several of the following apply:

• A diagnosis of Parkinson’s disease for at least five years (for Parkinson’s disease patients specifically)
• A genuine but shortening response to medication, with increasing “off” time
• Involuntary movements (dyskinesia) related to higher medication doses
• Tremor, in any of the relevant conditions, that has not responded adequately to medication
• No severe uncontrolled psychiatric illness and no significant cognitive decline
• General health sufficient for a planned neurosurgical procedure

Before any surgical plan is made, evaluation typically requires:

• Recent neurology reports and a detailed, current medication list with doses and timing
• Recent brain MRI
• Structured motor assessment, including levodopa response testing where relevant
• Neuropsychological and mood assessment
• Video recordings of motor symptoms (tremor, walking, stiffness) captured both “on” and “off” medication, which often provide more useful information than written descriptions alone

Once a patient is being actively worked up for surgery, imaging and pre-operative tests are typically repeated using protocol-specific scans on the same equipment used for surgical planning, since accurate targeting depends on this.

DBS is carried out in a single stage.

A stereotactic frame, a frameless navigation system, or a surgical robot holds the head in a known position relative to the planning scans, or guides instruments along the planned trajectory. Small openings are made in the skull and the electrodes are advanced to the planned target. For much of this stage, many patients are awake and comfortable, because the team needs to confirm the target through testing; delivering stimulation and observing its effect on tremor and rigidity directly, while the patient reports what they feel. The brain itself has no pain receptors, and local anesthetic covers the scalp; patients often describe the experience as long rather than painful. Where staying still or communicating during an awake procedure would be difficult, asleep techniques exist and can be discussed as an alternative; some robotic and intraoperative-imaging workflows are specifically designed to support this. Full detail on the robotic technique is on our Robotic-Assisted Deep Brain Stimulation page. Under general anesthesia, the pulse generator is implanted under the skin below the collarbone and connected to the electrodes by leads tunneled beneath the skin of the neck. Nothing is visible from the outside once healing is complete.

The stimulator is generally not switched on immediately. Swelling around the electrodes produces a temporary improvement in symptoms (the so-called “microlesion effect”) that would make early settings misleading, so programming usually begins a few days or weeks after surgery.

Programming is a gradual process rather than a single appointment. Over several sessions, the team adjusts which electrode contacts are active, along with voltage, pulse width and frequency, while medication is adjusted in parallel. Much of the benefit patients experience comes from this phase rather than from the operation alone. Ongoing, periodic follow-up continues over the long term to fine-tune settings as the condition or the patient’s needs change.

Air travel is generally restricted for at least ten to fourteen days after surgery, because changes in cabin pressure can be a concern while small amounts of air may remain trapped inside the skull.

DBS does not cure the underlying condition and does not stop it from progressing. In appropriately selected patients, it can reliably help to:

• Lengthen “on” periods when medication is working
• Reduce tremor, rigidity and slowness during those periods
• Reduce medication-induced involuntary movements
• Allow a meaningful reduction in daily medication dose, in many patients

Symptoms that tend not to improve include balance problems already present in the best medicated state, freezing of gait that does not respond to medication, and cognitive symptoms. Setting clear, realistic expectations about this distinction before surgery is one of the most important parts of the consultation process.

DBS is a neurosurgical procedure and carries real, though uncommon, risks, including bleeding within the brain, infection around the implanted hardware, lead movement or fracture, seizure, and stimulation-related side effects such as changes in speech, balance or mood. Many stimulation-related effects can be reduced or resolved through reprogramming, which is one of the practical advantages of a reversible, adjustable system.

The pulse generator has a finite battery. Non-rechargeable devices are typically replaced after several years in a short procedure; rechargeable devices last considerably longer but require regular charging by the patient. Which type suits a given patient is discussed individually, taking lifestyle and access to follow-up care into account.

Individual risk depends on age, general health and other factors, and is discussed specifically for each patient rather than presented as a single figure that applies to everyone.

Recovery runs alongside device programming, typically over a period of several weeks, during which physical therapy often continues in parallel. When stimulation reduces a tremor or rigidity that has been present for years, patients sometimes need to relearn tasks they had adapted around; the underlying movement improves, but old habits take time to catch up. Structured long-term follow-up continues after the initial programming period, to adjust settings as needed over time.